193 related articles for article (PubMed ID: 20506232)
1. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
2. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
Al-Shanti N; Saini A; Faulkner SH; Stewart CE
Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
Layne MD; Farmer SR
Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.
Foulstone EJ; Meadows KA; Holly JM; Stewart CE
J Cell Physiol; 2001 Nov; 189(2):207-15. PubMed ID: 11598906
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha.
Fernández-Celemín L; Pasko N; Blomart V; Thissen JP
Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1279-90. PubMed ID: 12388149
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
Saini A; Al-Shanti N; Sharples AP; Stewart CE
Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF-I) induces myotube hypertrophy associated with an increase in anaerobic glycolysis in a clonal skeletal-muscle cell model.
Semsarian C; Sutrave P; Richmond DR; Graham RM
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):443-51. PubMed ID: 10191278
[TBL] [Abstract][Full Text] [Related]
9. Isolation and validation of human prepubertal skeletal muscle cells: maturation and metabolic effects of IGF-I, IGFBP-3 and TNFalpha.
Grohmann M; Foulstone E; Welsh G; Holly J; Shield J; Crowne E; Stewart C
J Physiol; 2005 Oct; 568(Pt 1):229-42. PubMed ID: 16081485
[TBL] [Abstract][Full Text] [Related]
10. Myogenin, MyoD and IGF-I regulate muscle mass but not fiber-type conversion during resistance training in rats.
Aguiar AF; Vechetti-Júnior IJ; Alves de Souza RW; Castan EP; Milanezi-Aguiar RC; Padovani CR; Carvalho RF; Silva MD
Int J Sports Med; 2013 Apr; 34(4):293-301. PubMed ID: 23059557
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone stimulates mechano growth factor expression and activates myoblast transformation in C2C12 cells.
Imanaka M; Iida K; Murawaki A; Nishizawa H; Fukuoka H; Takeno R; Takahashi Y; Okimura Y; Kaji H; Chihara K
Kobe J Med Sci; 2008 May; 54(1):E46-54. PubMed ID: 18772608
[TBL] [Abstract][Full Text] [Related]
12. Pro- and anti-apoptotic roles for IGF-I in TNF-alpha-induced apoptosis: a MAP kinase mediated mechanism.
Saini A; Al-Shanti N; Faulkner SH; Stewart CE
Growth Factors; 2008 Oct; 26(5):239-53. PubMed ID: 18651291
[TBL] [Abstract][Full Text] [Related]
13. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
[TBL] [Abstract][Full Text] [Related]
14. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells.
Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M
J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045
[TBL] [Abstract][Full Text] [Related]
15. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.
Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F
Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422
[TBL] [Abstract][Full Text] [Related]
16. Impaired muscle regeneration and myoblast differentiation in mice with a muscle-specific KO of IGF-IR.
Heron-Milhavet L; Mamaeva D; LeRoith D; Lamb NJ; Fernandez A
J Cell Physiol; 2010 Oct; 225(1):1-6. PubMed ID: 20458740
[TBL] [Abstract][Full Text] [Related]
17. Reduction of myoblast differentiation following multiple population doublings in mouse C2 C12 cells: a model to investigate ageing?
Sharples AP; Al-Shanti N; Lewis MP; Stewart CE
J Cell Biochem; 2011 Dec; 112(12):3773-85. PubMed ID: 21826704
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma prevents TNF-alpha-induced apoptosis in C2C12 myotubes through down-regulation of TNF-R2 and increased NF-kappaB activity.
Tolosa L; Morlá M; Iglesias A; Busquets X; Lladó J; Olmos G
Cell Signal; 2005 Nov; 17(11):1333-42. PubMed ID: 16125053
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha regulation of insulin-like growth factor-I, type 1 IGF receptor, and IGF binding protein expression in cerebellum of transgenic mice.
Ye P; Price W; Kassiotis G; Kollias G; D'Ercole AJ
J Neurosci Res; 2003 Mar; 71(5):721-31. PubMed ID: 12584730
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy.
Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
FEBS J; 2006 Aug; 273(16):3709-21. PubMed ID: 16869890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
